John Evans owns 1.11% of Beam Therapeutics
1,150,205 shares as of the October 16, 2026 filing, worth $27M at the latest close.
BEAM · $2.4B market capGet an email when John Evans’s stake moves.
Free.
The stake
1.11%
worth $27M at the latest close
Stake rank
#1,050
by dollar value of the stake
Last sale
201 days ago
Apr 1, 2026
Last buy
None
no purchases since 2021
John Evans owns 1.11% of Beam Therapeutics Inc.: 1,150,205 of 103,287,665 shares, worth about $27M at the 2026-10-16 close. The stake has moved from 2.14% in 2020 to 1.11% on 2026-10-16, across 19 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $739,317 on 2026-04-01.
How the stake is held
as of the Oct 16, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 16, 2026 · Form 4 ↗
HELD DIRECTLY
1,047,205
91.0%
HELD INDIRECTLY · By John M. Evans, III 2018 Irrevocable Trust
103,000
9.0%
THE STAKE
1,150,205
1.11%